131 related articles for article (PubMed ID: 38404009)
1. Preventing Cancer by Inhibiting Ornithine Decarboxylase: A Comparative Perspective on Synthetic vs. Natural Drugs.
Sahu PN; Sen A
Chem Biodivers; 2024 Apr; 21(4):e202302067. PubMed ID: 38404009
[TBL] [Abstract][Full Text] [Related]
2. Regulation of polyamine homeostasis through an antizyme citrullination pathway.
Yang YF; Lee CY; Hsieh JY; Liu YL; Lin CL; Liu GY; Hung HC
J Cell Physiol; 2021 Aug; 236(8):5646-5663. PubMed ID: 33432662
[TBL] [Abstract][Full Text] [Related]
3. The rational discovery of multipurpose inhibitors of the ornithine decarboxylase.
Chai X; Zhan J; Pan J; He M; Li B; Wang J; Ma H; Wang Y; Liu S
FASEB J; 2020 Sep; 34(9):10907-12921. PubMed ID: 32767470
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy.
Geck RC; Foley JR; Murray Stewart T; Asara JM; Casero RA; Toker A
J Biol Chem; 2020 May; 295(19):6263-6277. PubMed ID: 32139506
[TBL] [Abstract][Full Text] [Related]
5. Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential.
Shantz LM; Levin VA
Amino Acids; 2007 Aug; 33(2):213-23. PubMed ID: 17443268
[TBL] [Abstract][Full Text] [Related]
6. A Label-Free Continuous Fluorescence-Based Assay for Monitoring Ornithine Decarboxylase Activity with a Synthetic Putrescine Receptor.
Nilam M; Gribbon P; Reinshagen J; Cordts K; Schwedhelm E; Nau WM; Hennig A
SLAS Discov; 2017 Aug; 22(7):906-914. PubMed ID: 28346093
[TBL] [Abstract][Full Text] [Related]
7. Involvement of antizyme in stabilization of ornithine decarboxylase caused by inhibitors of polyamine synthesis.
Murakami Y; Nishiyama M; Hayashi S
Eur J Biochem; 1989 Mar; 180(1):181-4. PubMed ID: 2495941
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
[TBL] [Abstract][Full Text] [Related]
9. Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity.
Kim DJ; Roh E; Lee MH; Oi N; Lim DY; Kim MO; Cho YY; Pugliese A; Shim JH; Chen H; Cho EJ; Kim JE; Kang SC; Paul S; Kang HE; Jung JW; Lee SY; Kim SH; Reddy K; Yeom YI; Bode AM; Dong Z
Cancer Res; 2016 Mar; 76(5):1146-1157. PubMed ID: 26676750
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening of natural inhibitors targeting ornithine decarboxylase with pharmacophore scaffolding of DFMO and validation by molecular dynamics simulation studies.
Sivashanmugam M; K N S; V U
J Biomol Struct Dyn; 2019 Feb; 37(3):766-780. PubMed ID: 29436980
[TBL] [Abstract][Full Text] [Related]
11. Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells.
Manni A; Wechter R; Gilmour S; Verderame MF; Mauger D; Demers LM
Int J Cancer; 1997 Jan; 70(2):175-82. PubMed ID: 9009157
[TBL] [Abstract][Full Text] [Related]
12. Purification and Characterization of Ornithine Decarboxylase from
El-Sayed ASA; George NM; Yassin MA; Alaidaroos BA; Bolbol AA; Mohamed MS; Rady AM; Aziz SW; Zayed RA; Sitohy MZ
Molecules; 2019 Jul; 24(15):. PubMed ID: 31362455
[TBL] [Abstract][Full Text] [Related]
13. Antizyme, a protein induced by polyamines, accelerates the degradation of ornithine decarboxylase in Chinese-hamster ovary-cell extracts.
Murakami Y; Tanaka K; Matsufuji S; Miyazaki Y; Hayashi S
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):661-4. PubMed ID: 1590755
[TBL] [Abstract][Full Text] [Related]
14. Ornithine decarboxylase activity in tumor cell lines correlates with sensitivity to cell death induced by histone deacetylase inhibitors.
Saunders LR; Verdin E
Mol Cancer Ther; 2006 Nov; 5(11):2777-85. PubMed ID: 17121924
[TBL] [Abstract][Full Text] [Related]
15. The antizyme family for regulating polyamines.
Kahana C
J Biol Chem; 2018 Nov; 293(48):18730-18735. PubMed ID: 30355739
[TBL] [Abstract][Full Text] [Related]
16. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
[TBL] [Abstract][Full Text] [Related]
17. Thrombin stimulates vascular smooth muscle cell polyamine synthesis by inducing cationic amino acid transporter and ornithine decarboxylase gene expression.
Durante W; Liao L; Peyton KJ; Schafer AI
Circ Res; 1998 Jul; 83(2):217-23. PubMed ID: 9686762
[TBL] [Abstract][Full Text] [Related]
18. Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications.
Thomas T; Thomas TJ
Breast Cancer Res Treat; 1994 Feb; 29(2):189-201. PubMed ID: 8012036
[TBL] [Abstract][Full Text] [Related]
19. Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs.
Ghoda L; Basu HS; Porter CW; Marton LJ; Coffino P
Mol Pharmacol; 1992 Aug; 42(2):302-6. PubMed ID: 1513327
[TBL] [Abstract][Full Text] [Related]
20. Characterization of ornithine decarboxylase and regulation by its antizyme in Thermus thermophilus.
Pantazaki AA; Anagnostopoulos CG; Lioliou EE; Kyriakidis DA
Mol Cell Biochem; 1999 May; 195(1-2):55-64. PubMed ID: 10395069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
